Future perspectives Looking forward, future research should focus on several key areas to advance the therapeutic landscape for ovarian cancer: Targeted Reprogramming of TAMs: Developing more precise and effective methods to shift TAMs from the M2 to the M1 phenotype is essential
PMID: 21593563 [vi] Park SA, Byeon G, Jhoo JH, Kim HC, Lim MN, Jang JW, Bae JB, Han JW, Kim TH, Kwak KP, Kim BJ, Kim SG, Kim JL, Moon SW, Park JH, Ryu SH, Youn JC, Lee DW, Lee SB, Lee JJ, Lee DY, Kim KW
Moreover, the tumor microbiota is positively correlated with mitochondrial metabolic activity [87, 88], forming a microbiotametabolismimmunity axis that underpins a multidimensional resistance network and offers new insights for next-generation tumor microenvironmenttargeted strategies
Semax and Selank are two neuropeptides that work well together
GHK-Cu is a copper-binding peptide that modulates tissue repair and collagen synthesis, while semaglutide is a GLP-1 receptor agonist that suppresses appetite and improves metabolic function